©The Author(s) 2025.
World J Gastrointest Oncol. Feb 15, 2025; 17(2): 98808
Published online Feb 15, 2025. doi: 10.4251/wjgo.v17.i2.98808
Published online Feb 15, 2025. doi: 10.4251/wjgo.v17.i2.98808
Table 1 Clinical characteristics of patients with esophageal squamous cell carcinoma
| Characteristics | ESCC, n |
| Sex | |
| Male | 33 |
| Female | 67 |
| Age | |
| < 60 years | 21 |
| ≥ 60 years | 79 |
| Length | |
| < 5 cm | 54 |
| ≥ 5 cm | 46 |
| Therapeutic modality | |
| Radiotherapy | 58 |
| Chemoradiotherapy | 42 |
| T stage | |
| T1–2 | 52 |
| T3–4 | 48 |
| Lymph node metastasis | |
| N0–1 | 93 |
| N2–3 | 7 |
| TNM stage | |
| I-II | 75 |
| III-IV | 25 |
- Citation: Ge YY, Xia XC, Wu AQ, Ma CY, Yu LH, Zhou JY. Identifying adipocyte-derived exosomal miRNAs as potential novel prognostic markers for radiotherapy of esophageal squamous cell carcinoma. World J Gastrointest Oncol 2025; 17(2): 98808
- URL: https://www.wjgnet.com/1948-5204/full/v17/i2/98808.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i2.98808